RSS
|
|
|
Category:Organofluorides Category:Otologicals es:Acetónido de fluocinolona fa:فلوئوسینولون it:Fluocinolone acetonide hu:Fluocinolon-acetonid pl:Fluocynolon ru:Синафлан |
Fluocinolone acetonide
|
| ||||||||||||||||||||||||||||||
|
Want to Fluocinolone acetonide latest news on your twitter account???  Fluocinolone acetonide || Drugs || Health |
Alimera resubmits NDA - ModernMedicine  ModernMedicine--Atlanta�Alimera Sciences Inc. resubmitted its new drug application, or NDA, for an investigational intravitreal insert containing -fluocinolone acetonide- (Iluvien) to the FDA May 12. This resubmission attempts to address the FDA's re - Date : Mon, 23 May 2011 22:08:14 GMT+00:00 |
| Alimera Sciences resubmits new drug application - OSN SuperSite OSN SuperSite--ATLANTA � Alimera Sciences has resubmitted a new drug application for -fluocinolone acetonide- implants to address a complete response letter from the US Food and Drug Administration, the company announced in a press release. ... - Date : Mon, 16 May 2011 15:29:05 GMT+00:00 |
| pSivida Announces New Safety and Efficacy Data from Phase 3 Study of ILUVIEN ... - PharmaLive.com (press release) PharmaLive.com (press release)---...- involving 956 patients in sites across the United States, Canada, Europe and India to assess the efficacy and safety of ILUVIEN with two doses of the corticosteroid -fluocinolone acetonide- (FAc), a high and low dose, - Date : Tue, 03 May 2011 13:58:20 GMT+00:00 |
| Alimera's New 36-Month Safety and Efficacy Results From the Phase 3 Fame(TM ... - TradersHuddle.com (press release) TradersHuddle.com (press release)---...- involving 956 patients in sites across the United States, Canada, Europe and India to assess the efficacy and safety of ILUVIEN with two doses of the corticosteroid -fluocinolone acetonide- (FAc), a high and low do - Date : Tue, 03 May 2011 13:28:32 GMT+00:00 |
| Alimera Sciences Announces Upcoming Company Events - GlobeNewsWire (press release) GlobeNewsWire (press release)--Its advanced product candidate, ILUVIEN®, is an intravitreal insert containing -fluocinolone acetonide-, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. ILUVIEN® is an invest - Date : Tue, 26 Apr 2011 15:25:24 GMT+00:00 |
| FAME results suggest steroid implant an efficacious treatment option for DME - OSN SuperSite OSN SuperSite--Twenty-four month results for two phase 3 clinical trials suggested that low- and high-dose -fluocinolone acetonide- implants may be efficacious in treating diabetic macular edema, with the low-dose implant offering a superior risk-to-benef - Date : Fri, 29 Apr 2011 14:31:14 GMT+00:00 |
| Alimera Sciences Inc (ALIM) Posts Large Volume Increase, Hits $7.05 - American Banking News American Banking News--Iluvien is an intravitreal insert designed to provide a sustained therapeutic effect for up to 36 months by delivering a low daily dose of -fluocinolone acetonide- (FA), a corticosteroid with demonstrated efficacy in the treatment o - Date : Fri, 18 Mar 2011 19:04:18 GMT+00:00 |
| Alimera Sciences to Hold Conference Call to Discuss Results From the Final ... - GlobeNewsWire (press release) GlobeNewsWire (press release)--Its advanced product candidate, ILUVIEN®, is an intravitreal insert containing -fluocinolone acetonide-, a non-proprietary corticosteroid with demonstrated ... - Date : Thu, 27 Jan 2011 11:32:59 GMT+00:00 |
| PSivida Announces $10.75 Million Registered Direct Financing - TheStreet.com (press release) (blog) TheStreet.com (press release) (blog)--The Company's most advanced product candidate, Iluvien (R) , delivers -fluocinolone acetonide- (FA) for the treatment of diabetic macular edema. ... - Date : Thu, 20 Jan 2011 17:34:16 GMT+00:00 |
| pSivida Completes Previously Announced Registered Direct Financing - PharmaLive.com (press release) PharmaLive.com (press release)--The Company's most advanced product candidate, Iluvien (R) , delivers -fluocinolone acetonide- (FA) for the treatment of diabetic macular edema. ... - Date : Tue, 25 Jan 2011 19:06:54 GMT+00:00 |
| Antihemorrhoidals for topical use | corticosteroids (Hydrocortisone, Prednisolone, Betamethasone, Fluorometholone, Fluocortolone, Dexamethasone, Fluocinolone acetonide, Fluocinonide) local anesthetics (Lidocaine, Tetracaine, Benzocaine, Cinchocaine, Procaine, Oxetacaine, Pramocaine) other (Tribenoside) | |
| Antivaricose therapy | heparins or heparinoids for topical use (Organo-heparinoid, Sodium apolate, Heparin, Pentosan polysulfate) sclerosing agents for local injection (Monoethanolamine oleate, Polidocanol, Invert sugar, Sodium tetradecyl sulfate, Phenol) other (Calcium dobesilate) | |
| Capillary stabilising agents | bioflavonoids (Rutoside, Monoxerutin, Diosmin, Troxerutin, Hidrosmin) - other (Tribenoside) | |
| Anti-infectives | Acetic acid * Aluminium acetotartrate * Boric acid * Chloramphenicol * Chlorhexidine * Ciprofloxacin * Clioquinol * Gentamicin * Hydrogen peroxide * Miconazole * Neomycin * Nitrofurazone * Ofloxacin * Polymyxin B * Rifamycin * Tetracycline | |
| Corticosteroids | Betamethasone * Dexamethasone * Fluocinolone acetonide * Hydrocortisone * Prednisolone | |
| Analgesics and anesthetics | Lidocaine * Cocaine * Phenazone | |